Skip to main content
Figure 3 | Genome Medicine

Figure 3

From: Novel proteins associated with risk for coronary heart disease or stroke among postmenopausal women identified by in-depth plasma proteome profiling

Figure 3

Baseline plasma B2M concentrations for CHD cases and controls, and IGFBP4 concentrations for stroke cases and controls, from the Women's Health Initiative hormone therapy trials. Individual ELISA-based concentrations are shown along with boxplots showing the median (dark line) and the 25th and 75th percentiles (bottom and top of box). The notches indicate 95% confidence intervals for the median.

Back to article page

Genome Medicine

ISSN: 1756-994X

Contact us